(function(){var loadHandler=window['sl_{D0ADD9BC-5BCE-4B01-85F9-188A7AEC90E6}'];loadHandler&&loadHandler(167, '<div id="spr0_aef82af"><div id="spr1_aef82af" class="kern slide"><img id="img4_aef82af" src="data/img2.png" width="720px" height="540px" alt="" style="left:0px;top:0px;"/></div><div id="spr2_aef82af" class="kern slide"><div id="spr3_aef82af" style="left:552.123px;top:392.412px;"><div style="width:0px;"><span id="txt0_aef82af" data-width="74.833984" style="left:17.107px;top:1.07px;">AZD9496</span></div><div style="width:0px;"><span id="txt1_aef82af" data-width="94.482422" style="left:7.727px;top:25.323px;">Astra Zeneca</span></div></div><div id="spr4_aef82af" style="left:288.66px;top:495.498px;"><div style="width:0px;"><span id="txt2_aef82af" class="relpos" style="left:7.2px;top:3.195px;"> </span><span id="txt3_aef82af" class="relpos" data-width="61.845703" style="left:7.195px;top:1.07px;">THIQ40</span><span id="txt4_aef82af" class="relpos" data-width="76.324219" style="left:7.19px;top:3.195px;"> (Novartis)</span></div></div><div id="spr5_aef82af" style="left:273.254px;top:314.859px;"><div id="spr6_aef82af"><img id="img0_aef82af" src="data/img171.png" width="196.5" height="177.75" alt=""/></div><div id="svg0_aef82af" style="left:153.582px;top:131.764px;"><svg width="57" height="51" viewBox="-1 -1 57 51"><path fill="#ffffff" stroke="#ffffff" stroke-width="2" stroke-linecap="butt" stroke-linejoin="round" d="M1,1 h52.138 v46.875 h-52.138 Z"/></svg></div></div><div id="spr7_aef82af"><div style="width:0px;"><span id="txt5_aef82af" class="relpos" data-width="101.048828" style="left:23.731px;top:0.058px;">Novel ER</span><span id="txt6_aef82af" class="relpos" data-width="22.216797" style="left:23.726px;top:0.058px;">α </span><span id="txt7_aef82af" class="relpos" data-width="324.556641" style="left:23.721px;top:0.058px;">“antagonists and degraders”</span></div><div style="width:0px;"><span id="txt8_aef82af" data-width="225.667969" style="left:133.571px;top:33.658px;">under development</span></div></div><div id="spr8_aef82af" style="left:497.062px;top:189.162px;"><div id="spr9_aef82af" style="left:27.069px;"><img id="img1_aef82af" src="data/img172.png" width="161.25" height="203.25" alt=""/></div><div id="svg1_aef82af" style="left:-1px;top:76.188px;"><svg width="57" height="51" viewBox="-1 -1 57 51"><path fill="#ffffff" stroke="#ffffff" stroke-width="2" stroke-linecap="butt" stroke-linejoin="round" d="M1,1 h52.138 v46.875 h-52.138 Z"/></svg></div></div><div id="spr10_aef82af" style="left:27.357px;top:161.529px;"><img id="img2_aef82af" src="data/img173.png" width="202.5" height="232.5" alt="" style="left:0.09px;top:-0.057px;"/></div><div id="spr11_aef82af" style="left:55.533px;top:393.877px;"><div style="width:0px;"><span id="txt9_aef82af" data-width="76.533203" style="left:7.644px;top:1.07px;">RAD1901</span></div><div style="width:0px;"><span id="txt10_aef82af" data-width="41.264648" style="left:25.419px;top:25.323px;">Pfizer</span></div></div><div id="spr12_aef82af" style="left:294.874px;top:146.568px;"><div id="spr13_aef82af"><img id="img3_aef82af" src="data/img170.png" width="123" height="138.75" alt="" style="left:0.076px;top:-0.076px;"/></div><div id="svg2_aef82af" style="top:10.918px;"><svg width="82" height="27" viewBox="0 0 82 27"><path fill="none" d="M0,0 h81.599 v26.658 h-81.599 Z"/></svg></div><div id="spr14_aef82af" style="top:10.918px;"><div style="width:0px;"><span id="txt11_aef82af" data-width="68.531250" style="left:7.595px;top:1.576px;">Tamoxifen</span></div></div><div id="svg3_aef82af" style="left:0.572px;top:116.844px;"><svg width="31" height="23" viewBox="-1 -1 31 23"><path fill="#ffffff" stroke="#ffffff" stroke-width="2" stroke-linecap="butt" stroke-linejoin="round" d="M1,1 h26.069 v18.857 h-26.069 Z"/></svg></div></div><div id="spr15_aef82af" style="top:80.193px;"><div style="width:0px;"><span id="txt12_aef82af" data-width="590.634766" style="left:65.45px;top:1.07px;"> Success of Fulvestrant-500 and discovery of activating ER LBD mutations</span></div><div style="width:0px;"><span id="txt13_aef82af" data-width="450.410156" style="left:135.925px;top:25.07px;">triggered a new wave of research in oral ER antagonists</span></div></div><div id="spr16_aef82af" style="left:49.295px;top:444.769px;"><div style="width:0px;"><span id="txt14_aef82af" data-width="89.349609" style="left:7.704px;top:2.082px;">Wardell et al 2015</span></div><div style="width:0px;"><span id="txt15_aef82af" data-width="81.445313" style="left:11.194px;top:16.482px;">PMID: 26162914</span></div></div><div id="spr17_aef82af" style="left:557.997px;top:444.769px;"><div style="width:0px;"><span id="txt16_aef82af" data-width="74.542969" style="left:11.485px;top:2.082px;">Weir et al 2016</span></div><div style="width:0px;"><span id="txt17_aef82af" data-width="81.445313" style="left:7.67px;top:16.482px;">PMID: 27020862</span></div></div><div id="spr18_aef82af" style="left:279.123px;top:517.918px;"><div style="width:0px;"><span id="txt18_aef82af" data-width="165.275391" style="left:7.2px;top:2.082px;">Burks et al 2017, PMID: 28296398</span></div></div></div></div>');})();